title: The safety of biological medicines for rheumatoid arthritis.
authors.affiliation: Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Athens, Athens, Greece, gianpapadopoulos@gmail.com.
authors.forename: Ioannis
authors.initials: I
authors.lastname: Papadopoulos
authors.forename: Costas
authors.initials: C
authors.lastname: Demetzos
authors.forename: Sofia
authors.initials: S
authors.lastname: Markantoni-Kyroudi
authors.forename: Kyriakos
authors.initials: K
authors.lastname: Souliotis
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001688:Biological Products / Q000008:administration & dosage / Q000009:adverse effects*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D007239:Infections / Q000209:etiology; D007249:Inflammation / Q000209:etiology; D007267:Injections / Q000009:adverse effects; D009140:Musculoskeletal Diseases / Q000139:chemically induced
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products